Global Sintilimab Injection Market Growth 2026-2032

April 2026 | 82 pages | ID: GD5AFBDF6DC1EN
LP Information

Abstracts

The global Sintilimab Injection market size is predicted to grow from US$ 169 million in 2025 to US$ 277 million in 2032; it is expected to grow at a CAGR of 7.5% from 2026 to 2032.

Sintilimab, marketed as TYVYT? (sintilimab injection) in China, is a PD-1 immunoglobulin G4 monoclonal antibody co-developed by Innovent and Eli Lilly and Company. Sintilimab is a type of immunoglobulin G4 monoclonal antibody, which binds to PD-1 molecules on the surface of T-cells, blocks the PD-1 / PD-Ligand 1 (PD-L1) pathway, and reactivates T-cells to kill cancer cells. Innovent is currently conducting more than 20 clinical studies of sintilimab to evaluate its safety and efficacy in a wide variety of cancer indications, including more than 10 registrational or pivotal clinical trials.

United States market for Sintilimab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Sintilimab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Sintilimab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Sintilimab Injection players cover Innovant Biologics, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the ?Sintilimab Injection Industry Forecast? looks at past sales and reviews total world Sintilimab Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Sintilimab Injection sales for 2026 through 2032. With Sintilimab Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sintilimab Injection industry.

This Insight Report provides a comprehensive analysis of the global Sintilimab Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sintilimab Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Sintilimab Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sintilimab Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sintilimab Injection.

This report presents a comprehensive overview, market shares, and growth opportunities of Sintilimab Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 100mg/10ml
• Others

Segmentation by Application:

• Hospitals
• Clinics
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Innovant Biologics, Inc.

Key Questions Addressed in this Report

• What is the 10-year outlook for the global Sintilimab Injection market?
• What factors are driving Sintilimab Injection market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Sintilimab Injection market opportunities vary by end market size?
• How does Sintilimab Injection break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Sintilimab Injection Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Sintilimab Injection by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Sintilimab Injection by Country/Region, 2021, 2025 & 2032
2.2 Sintilimab Injection Segment by Type
  2.2.1 100mg/10ml
  2.2.2 Others
  2.2.3 Sintilimab Injection Sales by Type
    2.2.3.1 Global Sintilimab Injection Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Sintilimab Injection Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Sintilimab Injection Sale Price by Type (2021-2026)
2.3 Sintilimab Injection Segment by Application
  2.3.1 Hospitals
  2.3.2 Clinics
  2.3.3 Others
  2.3.4 Sintilimab Injection Sales by Application
    2.3.4.1 Global Sintilimab Injection Sale Market Share by Application (2021-2026)
    2.3.4.2 Global Sintilimab Injection Revenue and Market Share by Application (2021-2026)
    2.3.4.3 Global Sintilimab Injection Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Sintilimab Injection Breakdown Data by Company
  3.1.1 Global Sintilimab Injection Annual Sales by Company (2021-2026)
  3.1.2 Global Sintilimab Injection Sales Market Share by Company (2021-2026)
3.2 Global Sintilimab Injection Annual Revenue by Company (2021-2026)
  3.2.1 Global Sintilimab Injection Revenue by Company (2021-2026)
  3.2.2 Global Sintilimab Injection Revenue Market Share by Company (2021-2026)
3.3 Global Sintilimab Injection Sale Price by Company
3.4 Key Manufacturers Sintilimab Injection Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Sintilimab Injection Product Location Distribution
  3.4.2 Players Sintilimab Injection Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR SINTILIMAB INJECTION BY GEOGRAPHIC REGION

4.1 World Historic Sintilimab Injection Market Size by Geographic Region (2021-2026)
  4.1.1 Global Sintilimab Injection Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Sintilimab Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Sintilimab Injection Market Size by Country/Region (2021-2026)
  4.2.1 Global Sintilimab Injection Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Sintilimab Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Sintilimab Injection Sales Growth
4.4 APAC Sintilimab Injection Sales Growth
4.5 Europe Sintilimab Injection Sales Growth
4.6 Middle East & Africa Sintilimab Injection Sales Growth

5 AMERICAS

5.1 Americas Sintilimab Injection Sales by Country
  5.1.1 Americas Sintilimab Injection Sales by Country (2021-2026)
  5.1.2 Americas Sintilimab Injection Revenue by Country (2021-2026)
5.2 Americas Sintilimab Injection Sales by Type (2021-2026)
5.3 Americas Sintilimab Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Sintilimab Injection Sales by Region
  6.1.1 APAC Sintilimab Injection Sales by Region (2021-2026)
  6.1.2 APAC Sintilimab Injection Revenue by Region (2021-2026)
6.2 APAC Sintilimab Injection Sales by Type (2021-2026)
6.3 APAC Sintilimab Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Sintilimab Injection by Country
  7.1.1 Europe Sintilimab Injection Sales by Country (2021-2026)
  7.1.2 Europe Sintilimab Injection Revenue by Country (2021-2026)
7.2 Europe Sintilimab Injection Sales by Type (2021-2026)
7.3 Europe Sintilimab Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Sintilimab Injection by Country
  8.1.1 Middle East & Africa Sintilimab Injection Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Sintilimab Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Sintilimab Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Sintilimab Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sintilimab Injection
10.3 Manufacturing Process Analysis of Sintilimab Injection
10.4 Industry Chain Structure of Sintilimab Injection

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Sintilimab Injection Distributors
11.3 Sintilimab Injection Customer

12 WORLD FORECAST REVIEW FOR SINTILIMAB INJECTION BY GEOGRAPHIC REGION

12.1 Global Sintilimab Injection Market Size Forecast by Region
  12.1.1 Global Sintilimab Injection Forecast by Region (2027-2032)
  12.1.2 Global Sintilimab Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Sintilimab Injection Forecast by Type (2027-2032)
12.7 Global Sintilimab Injection Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Innovant Biologics, Inc.
  13.1.1 Innovant Biologics, Inc. Company Information
  13.1.2 Innovant Biologics, Inc. Sintilimab Injection Product Portfolios and Specifications
  13.1.3 Innovant Biologics, Inc. Sintilimab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Innovant Biologics, Inc. Main Business Overview
  13.1.5 Innovant Biologics, Inc. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Sintilimab Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Sintilimab Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 100mg/10ml
Table 4. Major Players of Others
Table 5. Global Sintilimab Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global Sintilimab Injection Sales Market Share by Type (2021-2026)
Table 7. Global Sintilimab Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Sintilimab Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Sintilimab Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Sintilimab Injection Sale by Application (2021-2026) & (K Units)
Table 11. Global Sintilimab Injection Sale Market Share by Application (2021-2026)
Table 12. Global Sintilimab Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Sintilimab Injection Revenue Market Share by Application (2021-2026)
Table 14. Global Sintilimab Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Sintilimab Injection Sales by Company (2021-2026) & (K Units)
Table 16. Global Sintilimab Injection Sales Market Share by Company (2021-2026)
Table 17. Global Sintilimab Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Sintilimab Injection Revenue Market Share by Company (2021-2026)
Table 19. Global Sintilimab Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Sintilimab Injection Producing Area Distribution and Sales Area
Table 21. Players Sintilimab Injection Products Offered
Table 22. Sintilimab Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Sintilimab Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Sintilimab Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Sintilimab Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Sintilimab Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Sintilimab Injection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Sintilimab Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Sintilimab Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Sintilimab Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Sintilimab Injection Sales by Country (2021-2026) & (K Units)
Table 34. Americas Sintilimab Injection Sales Market Share by Country (2021-2026)
Table 35. Americas Sintilimab Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Sintilimab Injection Sales by Type (2021-2026) & (K Units)
Table 37. Americas Sintilimab Injection Sales by Application (2021-2026) & (K Units)
Table 38. APAC Sintilimab Injection Sales by Region (2021-2026) & (K Units)
Table 39. APAC Sintilimab Injection Sales Market Share by Region (2021-2026)
Table 40. APAC Sintilimab Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Sintilimab Injection Sales by Type (2021-2026) & (K Units)
Table 42. APAC Sintilimab Injection Sales by Application (2021-2026) & (K Units)
Table 43. Europe Sintilimab Injection Sales by Country (2021-2026) & (K Units)
Table 44. Europe Sintilimab Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Sintilimab Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe Sintilimab Injection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Sintilimab Injection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Sintilimab Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Sintilimab Injection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Sintilimab Injection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Sintilimab Injection
Table 52. Key Market Challenges & Risks of Sintilimab Injection
Table 53. Key Industry Trends of Sintilimab Injection
Table 54. Sintilimab Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Sintilimab Injection Distributors List
Table 57. Sintilimab Injection Customer List
Table 58. Global Sintilimab Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Sintilimab Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Sintilimab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Sintilimab Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Sintilimab Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Sintilimab Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Sintilimab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Sintilimab Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Sintilimab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Sintilimab Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Sintilimab Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Sintilimab Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Sintilimab Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Sintilimab Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Innovant Biologics, Inc. Basic Information, Sintilimab Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Innovant Biologics, Inc. Sintilimab Injection Product Portfolios and Specifications
Table 74. Innovant Biologics, Inc. Sintilimab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Innovant Biologics, Inc. Main Business
Table 76. Innovant Biologics, Inc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Sintilimab Injection
Figure 2. Sintilimab Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sintilimab Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Sintilimab Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Sintilimab Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Sintilimab Injection Sales Market Share by Country/Region (2025)
Figure 10. Sintilimab Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 100mg/10ml
Figure 12. Product Picture of Others
Figure 13. Global Sintilimab Injection Sales Market Share by Type in 2026
Figure 14. Global Sintilimab Injection Revenue Market Share by Type (2021-2026)
Figure 15. Sintilimab Injection Consumed in Hospitals
Figure 16. Global Sintilimab Injection Market: Hospitals (2021-2026) & (K Units)
Figure 17. Sintilimab Injection Consumed in Clinics
Figure 18. Global Sintilimab Injection Market: Clinics (2021-2026) & (K Units)
Figure 19. Sintilimab Injection Consumed in Others
Figure 20. Global Sintilimab Injection Market: Others (2021-2026) & (K Units)
Figure 21. Global Sintilimab Injection Sale Market Share by Application (2025)
Figure 22. Global Sintilimab Injection Revenue Market Share by Application in 2026
Figure 23. Sintilimab Injection Sales by Company in 2026 (K Units)
Figure 24. Global Sintilimab Injection Sales Market Share by Company in 2026
Figure 25. Sintilimab Injection Revenue by Company in 2026 ($ millions)
Figure 26. Global Sintilimab Injection Revenue Market Share by Company in 2026
Figure 27. Global Sintilimab Injection Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Sintilimab Injection Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Sintilimab Injection Sales 2021-2026 (K Units)
Figure 30. Americas Sintilimab Injection Revenue 2021-2026 ($ millions)
Figure 31. APAC Sintilimab Injection Sales 2021-2026 (K Units)
Figure 32. APAC Sintilimab Injection Revenue 2021-2026 ($ millions)
Figure 33. Europe Sintilimab Injection Sales 2021-2026 (K Units)
Figure 34. Europe Sintilimab Injection Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Sintilimab Injection Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Sintilimab Injection Revenue 2021-2026 ($ millions)
Figure 37. Americas Sintilimab Injection Sales Market Share by Country in 2026
Figure 38. Americas Sintilimab Injection Revenue Market Share by Country (2021-2026)
Figure 39. Americas Sintilimab Injection Sales Market Share by Type (2021-2026)
Figure 40. Americas Sintilimab Injection Sales Market Share by Application (2021-2026)
Figure 41. United States Sintilimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Sintilimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Sintilimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Sintilimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Sintilimab Injection Sales Market Share by Region in 2026
Figure 46. APAC Sintilimab Injection Revenue Market Share by Region (2021-2026)
Figure 47. APAC Sintilimab Injection Sales Market Share by Type (2021-2026)
Figure 48. APAC Sintilimab Injection Sales Market Share by Application (2021-2026)
Figure 49. China Sintilimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Sintilimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Sintilimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Sintilimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. India Sintilimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Sintilimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Sintilimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Sintilimab Injection Sales Market Share by Country in 2026
Figure 57. Europe Sintilimab Injection Revenue Market Share by Country (2021-2026)
Figure 58. Europe Sintilimab Injection Sales Market Share by Type (2021-2026)
Figure 59. Europe Sintilimab Injection Sales Market Share by Application (2021-2026)
Figure 60. Germany Sintilimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. France Sintilimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Sintilimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Sintilimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Sintilimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Sintilimab Injection Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Sintilimab Injection Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Sintilimab Injection Sales Market Share by Application (2021-2026)
Figure 68. Egypt Sintilimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Sintilimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Sintilimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Sintilimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Sintilimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Sintilimab Injection in 2026
Figure 74. Manufacturing Process Analysis of Sintilimab Injection
Figure 75. Industry Chain Structure of Sintilimab Injection
Figure 76. Channels of Distribution
Figure 77. Global Sintilimab Injection Sales Market Forecast by Region (2027-2032)
Figure 78. Global Sintilimab Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Sintilimab Injection Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Sintilimab Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Sintilimab Injection Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Sintilimab Injection Revenue Market Share Forecast by Application (2027-2032)